贊宇科技(002637.SZ):目前馬來西亞項目公司已完成註冊
格隆匯6月19日丨有投資者在投資者互動平台向贊宇科技(002637.SZ)提問,“公司在生物柴油方面是如何佈局的?請談談中遠期策略和市場方向。”
公司回覆稱,目前馬來西亞項目公司已完成註冊。具體產品方案將由公司相關團隊考察論證後推進,屆時請及時關注項目進展。公司規劃在馬來西亞投資建設油脂化學品項目,是公司戰略性佈局,依託馬來西亞原料、運輸、税收等優勢,有助於進一步提升公司在海外市場的綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.